Abbott Activated Alanine Aminotransferase Reagent May Produce Inaccurate Patient Results
Abbott's A-ALT diagnostic reagent may produce inaccurate test results for samples with elevated enzyme or bilirubin levels, potentially affecting patient outcomes. The affected reagent kits have been distributed worldwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II in vitro diagnostic recall with potential for inaccurate patient test results that could affect treatment decisions. No reported illnesses or injuries to date, placing this in the high-risk category for products where injury has not yet been reported.
Plain-English summary
Abbott Laboratories is recalling certain lots of its Activated Alanine Aminotransferase (A-ALT) diagnostic reagent (REF 8L92-42), used with Architect laboratory analyzers.
The affected reagent lots may produce inaccurate test results in two scenarios. The reagent may show greater than 10% under-recovery for samples with alanine aminotransferase levels above 1,200 units per liter, producing false low results. Additionally, the reagent may display a greater than 10% shift in results for samples containing bilirubin concentrations above 31 milligrams per deciliter. These inaccuracies could lead to incorrect patient results.
The recall involves 2,212 units with distribution in the United States (including Virginia, Utah, Texas, Tennessee, South Dakota, Pennsylvania, New York, Maine, Idaho, and California) and numerous countries worldwide.
The affected lot numbers are: 84126UN20 (expires 09JUL2021), 03676UN20 (expires 25AUG2021), 10597UN20 (expires 29AUG2021), 26275UN20 (expires 20OCT2021), 77748UN20 (expires 08DEC2021), 65958UN20 (expires 08DEC2021), and 81824UN21 (expires 16FEB2022).
The recalled product
- Product
- REF 8L92-42, Abbott Activated Alanine Aminotransferase, for use with Architect, IVD, CE, UDI: (01) 00380740161866
- Manufacturer
- Abbott Laboratories
- Affected units
- 2,212
Distribution
Part of a larger recall action
This product is one of 4 recalled by Abbott Laboratories under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Abbott Laboratories
See all →- HighChemistry analyzer control modules recalled over software that may give erroneous results
FDA (Devices) · 2025-12-24
- HighHematology analyzers recalled because saturation flags may not be applied
FDA (Devices) · 2025-11-19
- HighCELL-DYN Ruby hematology analyzer system expiration date validation
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby Hematology Analyzer Expiration Date Software Defect
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby hematology analyzer expiration date software defect
FDA (Devices) · 2025-04-30
Same hazard · test inaccuracy
See all →- ModerateLeadCare II Blood Lead Test Kit Recall for Inaccurate Results
FDA (Devices) · 2026-04-29
- ModerateOrtho Clinical Diagnostics Total Bili-Alkp XT Reagent Recall
FDA (Devices) · 2025-06-04
- ModerateORTHO CLINICAL DIAGNOSTICS VITROS BUN Reagent Recall Nationwide
FDA (Devices) · 2025-06-04
- HighSiemens Atellica CH Cuvette Segment manufacturing defect may impact lab test accuracy
FDA (Devices) · 2024-11-27
- HighRandox Clinical Chemistry Calibration Serum Recalled for Measurement Bias
FDA (Devices) · 2024-05-15